Diorganotin(IV) N-methyl-N-phenethyldithiocarbamate compounds induce cytotoxicity via apoptosis in K562 human erythroleukaemia cells
Imatinib mesylate (IM), a leading treatment for chronic myeloid leukaemia (CML), has sparked worries about the possibility of CML patients developing a resistance to it. As a result, researchers are becoming more interested in organotin(IV) compounds due to their strong potential to be developed as...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2023
|
Online Access: | http://journalarticle.ukm.my/22159/1/SL%2014.pdf |